Strategy Planning

 
GenEra-Illustration-05-00.jpg
 

GenEra Consulting’s advanced global medical affairs strategy solutions are underpinned by:

  • First-hand knowledge of the science behind cell and gene therapies

  • Insight-driven medical plans built to align teams and improve outcomes

  • Peerless scientific communications – building your narrative from external expert partnerships and scientific communication platform development through to publications planning and delivery

  • Medical education combining disease area and novel platform expertise with multi-channel strategies designed to advance understanding and enhance care

 
 
 
Matt-Booth.jpg

Learn more About Us >

“Cell and gene therapies are exquisitely unique so your medical and scientific communications must be too. The science behind a therapy has never had to work so hard, and has never needed to be so diverse in nature. Being able to understand these scientific needs with a full eye on regulatory and clinical requirements requires a special set of skills; skills that abound at GenEra Consulting”
— Dr Matthew Booth, SVP, Global Practice Lead, MEDiSTRAVA
 
 
 
 
 

Learn more About Us >

“Cell and gene therapies are clearly transforming how we treat and potentially cure many diseases but the path to market is complex with many challenges across multiple areas. GenEra Consulting draws upon its broad experiences and deep therapeutic expertise to help our Clients successfully navigate this journey and build towards improved outcomes for patients”
— Phil Wakefield, Chief Advisory Services and Evidence Communications Officer, Inizio Medical
 
 
 

Case study:

Support for the global adoption of an autologous ex vivo lentiviral gene therapy program

Challenge: To drive earlier diagnosis of rare neurometabolic disorders and primary immunodeficiencies, increase awareness of ex vivo gene therapy, and ensure all communications are meaningful, accurate and consistent

Approach: Internal stakeholder interviews to align on the scientific story, establishing communication priorities. Pressure test key concepts to refine the scientific story and ensure messages resonated with the clinical community

Results: Repository of evidence-driven key statements and slide banks – the foundation of all internal and external communications and activities. Creation of a compelling ‘reason to believe’, differentiating the early gene therapy program through language, enabling proactive market education

 
 
 

Wherever you are on your journey, our team would love to discuss it with you and help identify the best path forward.

 
 
 
 
 
 
 
GenEra-Illustration-05-06.jpg